BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29889413)

  • 1. Vaccine prospects against hepatitis C.
    Roingeard P
    Bull Acad Natl Med; 2016 Jan; 200(1):59-65. PubMed ID: 29889413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine.
    Beaumont E; Patient R; Hourioux C; Dimier-Poisson I; Roingeard P
    Hepatology; 2013 Apr; 57(4):1303-13. PubMed ID: 23150224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C vaccine. Need of the hour.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2014; 10(7):1927-9. PubMed ID: 25424801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
    Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ
    J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prophylactic hepatitis C virus vaccine: a distant peak still worth climbing.
    Baumert TF; Fauvelle C; Chen DY; Lauer GM
    J Hepatol; 2014 Nov; 61(1 Suppl):S34-44. PubMed ID: 25443345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses to hepatitis C virus (HCV) infection and the prospects for an effective HCV vaccine or immunotherapies.
    Lauer GM
    J Infect Dis; 2013 Mar; 207 Suppl 1():S7-S12. PubMed ID: 23390305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and Promise of a Hepatitis C Virus Vaccine.
    Cox AL
    Cold Spring Harb Perspect Med; 2020 Feb; 10(2):. PubMed ID: 31548228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis C virus vaccine].
    Wakita T
    Nihon Rinsho; 2008 Oct; 66(10):1961-4. PubMed ID: 18939497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in hepatitis C virus vaccines, Part one: Advances in basic knowledge for hepatitis C virus vaccine design.
    Roohvand F; Kossari N
    Expert Opin Ther Pat; 2011 Dec; 21(12):1811-30. PubMed ID: 22022980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA vaccine expressing the non-structural proteins of hepatitis C virus diminishes the expression of HCV proteins in a mouse model.
    Wada T; Kohara M; Yasutomi Y
    Vaccine; 2013 Dec; 31(50):5968-74. PubMed ID: 24144476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for a vaccine against the hepatitis C virus.
    Houghton M; Abrignani S
    Nature; 2005 Aug; 436(7053):961-6. PubMed ID: 16107836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for prophylactic hepatitis C vaccines based on virus-like particles.
    Beaumont E; Roingeard P
    Hum Vaccin Immunother; 2013 May; 9(5):1112-8. PubMed ID: 23406827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The development of therapeutic vaccine for hepatitis C virus].
    Kimura K; Kohara M
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1451-7. PubMed ID: 23064054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hepatitis B and C in Egypt and Africa.
    Attia MA
    Antivir Ther; 1998; 3(Suppl 3):1-9. PubMed ID: 10726051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
    Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods to Evaluate Novel Hepatitis C Virus Vaccines.
    Ahlén G; Frelin L
    Methods Mol Biol; 2016; 1403():221-44. PubMed ID: 27076133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic vaccines against hepatitis C virus.
    Xue J; Zhu H; Chen Z
    Infect Genet Evol; 2014 Mar; 22():120-9. PubMed ID: 24462908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New approaches to immune against hepatitis C virus].
    Sela B
    Harefuah; 2002 Dec; 141(12):1076-80, 1089. PubMed ID: 12534208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus vaccines--progress and perspectives.
    Fauvelle C; Lepiller Q; Felmlee DJ; Fofana I; Habersetzer F; Stoll-Keller F; Baumert TF; Fafi-Kremer S
    Microb Pathog; 2013 May; 58():66-72. PubMed ID: 23499591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.